Both in Biotechnology
Neumora Therapeutics vs Anavex Life Sciences
Over the past year NMRA returned −79.7% and AVXL returned −83.1%; their daily moves had a correlation of 0.11.
NMRA −79.7% AVXL −83.1%Growth of $1, one year, split-adjusted
| Metric | NMRA | AVXL |
|---|---|---|
| Price | $0.5660 | $1.26 |
| Market cap | $106.3M | $116.8M |
| Today | −0.86% | +5.00% |
| 1 month | +20.2% | −21.3% |
| 6 months | −75.7% | −62.3% |
| Year to date | −68.4% | −64.6% |
| 1 year | −81.2% | −83.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $63.9M | $118.3M |
| Dividend yield | — | — |
| Volatility (60d) | 125.6% | 74.4% |
| Short % of float | 6.9% | 14.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).